If your interest is specifically the longevity matchup between a copper peptide and NAD+, read our honest side by side comparison of GHK-Cu and NAD+ as longevity tools, covering how each one works and which specific goals each is better suited to support
Dr McGuire has received consulting fees from Novo Nordisk, AstraZeneca, Pfizer, Altimmune, Ventyx Pharmaceuticals, Bayer, Lexicon, Applied Therapeutics, Intercept Pharmaceuticals, Esperion, Lilly USA, Boehringer Ingelheim, New Amsterdam, CSL Behring, Amgen, Neurotronics, Metsera, Kailera, and Alveus Pharma
A study in JAMAs Ophthalmology Journal found that those who have used GLP-1 drugs are at a higher risk of developing NAION than those who were prescribed alternative diabetes control medications
Individual results vary." That footnote matters more than it looks
Weight-based dosing at 0.2g per kg bodyweight
What is my alternative if I dont have this? she says